The renin-angiotensin system: a review of trials with angiotensin-converting enzyme inhibitors and angiotensin receptor blocking agents

被引:9
作者
Sleight, P [1 ]
机构
[1] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England
关键词
hypertension; left ventricular dysfunction; left ventricular hypertrophy; myocardial infarction; heart failure; cough; endothelium; plaque rupture;
D O I
10.1016/S1520-765X(02)90074-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin-converting enzyme (ACE) inhibitors have been very successful in patients with vascular disease, in particular for hypertension, left ventricular dysfunction and vascular protection. Angiotensin receptor blocking drugs (ARBs) were developed later and differ from ACE inhibitors in several ways. We are now beginning to see the results of large studies of ARBs in high-risk patients and some head-to-head comparisons between these two classes of drugs which reduce the actions of angiotensin II. This review considers these trials under the headings of heart failure, hypertension, renal function, and high-risk cardiovascular disease/coronary heart disease. (C) 2002 The European Society of Cardiology.
引用
收藏
页码:A53 / A57
页数:5
相关论文
共 23 条
[1]   Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment [J].
Andersen, NH ;
Mogensen, CE .
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2001, 2 (03) :146-152
[2]   Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations [J].
Balcells, E ;
Meng, QC ;
Johnson, WH ;
Oparil, S ;
DellItalia, LJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (04) :H1769-H1774
[3]  
BALL SG, 1993, LANCET, V342, P821
[4]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[5]  
COLLINS R, 1995, LANCET, V345, P669
[6]   Reactive oxygen species, metalloproteinases, and plaque stability [J].
Davies, MJ .
CIRCULATION, 1998, 97 (24) :2382-2383
[7]  
DEVITA C, 1994, LANCET, V343, P1115
[8]  
Gerstein HC, 2000, LANCET, V355, P253
[9]   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].
Lewis, EJ ;
Hunsicker, LG ;
Clarke, WR ;
Berl, T ;
Pohl, MA ;
Lewis, JB ;
Ritz, E ;
Atkins, RC ;
Rohde, R ;
Raz, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860
[10]  
LONN E, CIRCULATION, V103, P919